BPTH.O

Bio-Path Holdings Announces $4M At-The-Market Offering at $0.87 Per Share

authorIntellectia.AI

2024-10-092mins

Bio-Path Holdings has announced a significant financial move with the pricing of a $4.0 million at-the-market offering. The company has entered into definitive agreements to issue and sell a total of 4,597,702 shares of its common stock. Additionally, Bio-Path is offering series A warrants to purchase up to 6,407,657 shares of common stock and short-term series B warrants for the same number of shares. Each share of common stock, or its equivalent, is priced at $0.87, with the warrants included in a private placement that complies with Nasdaq's at-the-market pricing rules.

The series A and series B warrants are priced with an exercise price of $1.00 per share. They will become exercisable upon the effective date of stockholder approval for the issuance of shares upon warrant exercise, known as the Stockholder Approval Date. The series A warrants are set to expire five years from this date, while the series B warrants have a shorter expiration period of twenty-four months.

The closing of this offering is anticipated to occur around October 10, 2024, pending the satisfaction of customary closing conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering, facilitating the transaction and ensuring compliance with financial regulations.

Share

Want more financial insights delivered directly to your inbox?

Subscribe now and receive handpicked financial news, insights, and trending topics.